Premium
Frontispiece: Aza[6]helicene Platinum Complexes: Chirality Control of cis–trans Isomerism
Author(s) -
Mendola Daniele,
Saleh Nidal,
Vanthuyne Nicolas,
Roussel Christian,
Toupet Loïc,
Castiglione Franca,
Caronna Tullio,
Mele Andrea,
Crassous Jeanne
Publication year - 2014
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.201482371
Subject(s) - helicene , enantiopure drug , chirality (physics) , cis–trans isomerism , platinum , chemistry , ligand (biochemistry) , stereochemistry , molecule , enantioselective synthesis , organic chemistry , receptor , catalysis , physics , biochemistry , chiral symmetry , quantum mechanics , quark , nambu–jona lasinio model
In their Communication on page 5786 ff., J. Crassous and co‐workers show how cis – trans isomerism in [Pt II Cl 2 (4‐aza[6]helicene)PPh 3 ] is controlled by the racemic and enantiopure forms of the 4‐aza[6]helicene ligand.